PT83995B - Processo para a preparacao de composicoes farmaceuticas contendo sais mistos formados por alfa-cetoacidos de cadeia ramificada e l-aminoacidos basicos utilizaveis no tratamento da uremia - Google Patents

Processo para a preparacao de composicoes farmaceuticas contendo sais mistos formados por alfa-cetoacidos de cadeia ramificada e l-aminoacidos basicos utilizaveis no tratamento da uremia

Info

Publication number
PT83995B
PT83995B PT83995A PT8399586A PT83995B PT 83995 B PT83995 B PT 83995B PT 83995 A PT83995 A PT 83995A PT 8399586 A PT8399586 A PT 8399586A PT 83995 B PT83995 B PT 83995B
Authority
PT
Portugal
Prior art keywords
amino acids
basic
uremia
salts formed
treatment
Prior art date
Application number
PT83995A
Other languages
English (en)
Other versions
PT83995A (en
Inventor
Mackenzie Welser
Henri Bermudez
Claude Bordat
Original Assignee
Univ Johns Hopkins
Synthelabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Johns Hopkins, Synthelabo filed Critical Univ Johns Hopkins
Publication of PT83995A publication Critical patent/PT83995A/pt
Publication of PT83995B publication Critical patent/PT83995B/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/175—Amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Food Science & Technology (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Polymers & Plastics (AREA)
  • Obesity (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Mycology (AREA)
  • Nutrition Science (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Rheumatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Peptides Or Proteins (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PT83995A 1985-12-23 1986-12-22 Processo para a preparacao de composicoes farmaceuticas contendo sais mistos formados por alfa-cetoacidos de cadeia ramificada e l-aminoacidos basicos utilizaveis no tratamento da uremia PT83995B (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/812,164 US4752619A (en) 1985-12-23 1985-12-23 Nutritional supplement for treatment of uremia

Publications (2)

Publication Number Publication Date
PT83995A PT83995A (en) 1987-01-01
PT83995B true PT83995B (pt) 1989-09-14

Family

ID=25208721

Family Applications (1)

Application Number Title Priority Date Filing Date
PT83995A PT83995B (pt) 1985-12-23 1986-12-22 Processo para a preparacao de composicoes farmaceuticas contendo sais mistos formados por alfa-cetoacidos de cadeia ramificada e l-aminoacidos basicos utilizaveis no tratamento da uremia

Country Status (14)

Country Link
US (1) US4752619A (pt)
EP (1) EP0227545B1 (pt)
JP (1) JPS62270522A (pt)
KR (1) KR940002661B1 (pt)
AT (1) ATE67088T1 (pt)
AU (1) AU592395B2 (pt)
CA (1) CA1286990C (pt)
DE (1) DE3681420D1 (pt)
DK (2) DK622486D0 (pt)
ES (1) ES2025560T3 (pt)
FI (1) FI88581C (pt)
GR (1) GR3003272T3 (pt)
NO (1) NO865217L (pt)
PT (1) PT83995B (pt)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2615734B1 (fr) * 1987-05-27 1989-12-01 Synthelabo Compositions pharmaceutiques contenant un melange de sels de cetoacides et d'amino-acides utiles pour le traitement de l'uremie
FR2618331B1 (fr) * 1987-07-23 1991-10-04 Synthelabo Compositions pharmaceutiques utiles pour le traitement de l'uremie
SE8803144L (sv) * 1988-09-07 1990-03-08 Kabivitrum Ab Energisubstrat
SE8803143L (sv) * 1988-09-07 1990-03-08 Kabivitrum Ab Alternativa energisubstrat
GB8906158D0 (en) * 1989-03-17 1989-05-04 Powell & Scholefield Limited Dietary product
US4957938A (en) * 1989-06-21 1990-09-18 Abbott Laboratories Nutritional formulation for the treatment of renal disease
US5210098A (en) * 1990-09-21 1993-05-11 Regents Of The University Of Minnesota Use of pyruvate to treat acute renal failure
US5576287A (en) * 1994-04-29 1996-11-19 Wake Forest University Method for treating acute renal disease and failure
US5591736A (en) * 1995-07-03 1997-01-07 The Johns Hopkins University Method of retarding the progression of chronic renal failure
ES2311297T3 (es) * 1998-01-05 2009-02-01 The Johns Hopkins University Complemento para pacientes en dialisis.
CA2441542A1 (en) * 2001-04-04 2002-10-17 Critical Therapeutics, Inc. Method for preventing acute renal failure
ITTO20020672A1 (it) * 2002-07-26 2004-01-26 Medestea Res And Production S Composizioni farmaceutiche contenenti cheto-acidi per somministrazione endoperitoneale
PL1913946T3 (pl) 2005-07-08 2014-07-31 Toray Industries Środek terapeutyczny oraz sposób leczenia do złagodzenia mocznicy
JP2014512371A (ja) 2011-04-18 2014-05-22 ネステク ソシエテ アノニム α−ＨＩＣＡ及びシトルリンを含有する栄養組成物
US11484579B2 (en) 2017-11-29 2022-11-01 Edgar L Hull Vitamins and alpha keto acid compositions for use in a treatment program for chronic kidney disease patients
US11253496B2 (en) 2017-11-29 2022-02-22 Edgar L. Hull Alpha keto acid compositions for treating hypo-albuminemia

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2335215B2 (de) * 1972-07-13 1979-04-05 The Johns Hopkins University, Baltimore, Md. (V.St.A.) Verwendung einer Mischung bei der Bekämpfung von zur Urämie führenden Nierenerkrankungen
DE2516027A1 (de) * 1973-04-30 1975-10-16 Univ Johns Hopkins Arzneimittel zur foerderung der proteinsynthese und zur konservierung des stickstoffs im koerper
GB1442154A (en) * 1973-04-30 1976-07-07 Walser M Composition for promotion of protein synthesis and suppression of urea formation in the body
DE2759133A1 (de) * 1976-12-31 1978-07-13 Carmelo Prof Giordano Gemisch essentieller aminosaeuren und/oder analoger ketosaeuren und verwendung derselben diaetzusatz bei niereninsuffizienz
US4228099A (en) * 1978-03-17 1980-10-14 The Johns Hopkins University Ornithine and arginine salts of branched chain keto acids and uses in treatment of hepatic and renal disorders
US4320146A (en) * 1978-03-17 1982-03-16 The Johns Hopkins University Treatment of hepatic and renal disorders with ornithine and arginine salts of branched chain keto acids
US4296127A (en) * 1979-04-18 1981-10-20 The Johns Hopkins University Mixed salts of essential or semi-essential amino acids and nitrogen-free analogs thereof

Also Published As

Publication number Publication date
ATE67088T1 (de) 1991-09-15
DK168274B1 (da) 1994-03-07
KR870005639A (ko) 1987-07-06
DK622486D0 (da) 1986-12-22
PT83995A (en) 1987-01-01
FI865268A (fi) 1987-06-24
FI88581B (fi) 1993-02-26
DK622486A (da) 1987-06-24
US4752619A (en) 1988-06-21
EP0227545A3 (en) 1988-01-20
DE3681420D1 (de) 1991-10-17
FI865268A0 (fi) 1986-12-22
AU6691786A (en) 1987-06-25
JPS62270522A (ja) 1987-11-24
NO865217L (no) 1987-06-24
EP0227545B1 (en) 1991-09-11
ES2025560T3 (es) 1992-04-01
KR940002661B1 (ko) 1994-03-28
AU592395B2 (en) 1990-01-11
EP0227545A2 (en) 1987-07-01
FI88581C (fi) 1993-06-10
GR3003272T3 (en) 1993-02-17
NO865217D0 (no) 1986-12-22
CA1286990C (en) 1991-07-30

Similar Documents

Publication Publication Date Title
PT83995B (pt) Processo para a preparacao de composicoes farmaceuticas contendo sais mistos formados por alfa-cetoacidos de cadeia ramificada e l-aminoacidos basicos utilizaveis no tratamento da uremia
SE9402156D0 (sv) Farmaceutiska kompositioner innehållande salterna av s(+)-2- (4-isobutylfenyl)-propionsyra med basiska aminosyror
ES453476A1 (es) Procedimiento para proporcionar una fuente de proteinas en forma concentrada.
AR015074A1 (es) Producto nutricional liquido, composicion nutricionalmente completa y metodo para su preparacion
ES2058687T3 (es) Composicion nutritiva y su procedimiento de preparacion.
ES2159737T3 (es) Composiciones farmaceuticas y/o dieteticas con actividad antioxidante que contienen carnosina o derivados y aminoacidos ramificados.
PT923315E (pt) Formula nutricional para pacientes com fenilcetonuria
MX9401203A (es) Metodo para complementar niveles de amino acidos en animales rumiantes.
PT88086A (pt) Processo para a preparacao de composicoes farmaceuticas a base de sais de alfa-aminoacidos basicos e de alfa-ceto-analogos de aminoacidos de cadeia ramificada apropriadas para o tratamento da uremia
AU8230187A (en) N,n'-bis-amino acid-l-cystine-peptide-containing amino acid preparations for oral and parenteral administration
AU7100094A (en) Rumen-bypass fatty acid salt and protein dietary supplement for ruminants
ES2016917A6 (es) Producto alimenticio y procedimiento para preparar productos alimenticios con konjak anadido.
DK0714910T3 (da) Anvendelse af et decapeptid med aktivitet af benzodiazepintype til fremstilling af medikamenter og kosttilskud
BR9814766A (pt) Formulação de revitalização
JPS56125313A (en) Remedy for damage
ATE210111T1 (de) Feste zusammensetzungen für orale verabreichung die nicht-hygroskopische salze von l-carnitin- oder alkanoyl-l-carnitin mit 2-aminosulfonsäure enthalten
DE3772107D1 (de) Pharmazeutische zubereitung fuer orale verabreichung von eisensalzen, verwendbar zur behandlung von anaemien durch eisenmangel.
FR2053703A5 (en) Supplementary food for pregnant women
FI853504L (fi) Acetyldikarnitin.
RU93012680A (ru) Белково-витаминно-минеральная добавка для свиней

Legal Events

Date Code Title Description
MM3A Annulment or lapse

Free format text: LAPSE DUE TO NON-PAYMENT OF FEES

Effective date: 19990831